{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:22Z","timestamp":1786987522651,"version":"build-2736575974"},"reference-count":86,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["12020108"],"award-info":[{"award-number":["12020108"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002349","name":"Academy of Scientific Research & Technology","doi-asserted-by":"publisher","award":["PRISM 5202"],"award-info":[{"award-number":["PRISM 5202"]}],"id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.1016\/j.csbj.2025.03.034","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T10:31:28Z","timestamp":1742725888000},"page":"1460-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2"],"prefix":"10.34133","volume":"27","author":[{"given":"Noha Samir","family":"Taibe","sequence":"first","affiliation":[{"name":"Biotechnology Department, Faculty of Science, Cairo University, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Center of Scientific Excellence for Influenza Viruses (CSEIV), National Research Centre, Cairo 12622, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimona A.","family":"Kord","sequence":"additional","affiliation":[{"name":"Botany Department, Faculty of Science, Cairo University, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ahmed","family":"Badawy","sequence":"additional","affiliation":[{"name":"Chemistry Department, Faculty of Science, Cairo University, Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Shehata","sequence":"additional","affiliation":[{"name":"Center of Scientific Excellence for Influenza Viruses (CSEIV), National Research Centre, Cairo 12622, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Elhefnawi","sequence":"additional","affiliation":[{"name":"Biomedical Informatics and Cheminformatics Group, Informatics and Systems Department, National Research Centre, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2019.1581171"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.02.030"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030747"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25685"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2015.02.025"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221132736","article-title":"Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment","volume":"16","author":"Taibe N.S.","year":"2022","unstructured":"Taibe N.S. et al: Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment. Ther Adv Respir Dis 2022; 16. 17534666221132736.","journal-title":"Ther Adv Respir Dis"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"1112755","DOI":"10.3389\/fbioe.2023.1112755","article-title":"Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery","volume":"11","author":"Fopase R.","year":"2023","unstructured":"Fopase R. et al: Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery. Front Bioeng Biotechnol 2023; 11: 1112755.","journal-title":"Front Bioeng Biotechnol"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00272"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/nar\/gkab1248","article-title":"Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread","volume":"50","author":"Ambike S.","year":"2022","unstructured":"Ambike S. et al: Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread. Nucleic Acids Res 2022; 50: 333.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_11_2","article-title":"Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral Sequences","volume":"16","author":"Sun J.","year":"2024","unstructured":"Sun J. et al: Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral Sequences. Viruses 2024; 16.","journal-title":"Viruses"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1038\/s41598-021-88310-8","article-title":"A small interfering RNA (siRNA) database for SARS-CoV-2","volume":"11","author":"Medeiros I.G.","year":"2021","unstructured":"Medeiros I.G. et al: A small interfering RNA (siRNA) database for SARS-CoV-2. Sci Rep 2021; 11: 8849.","journal-title":"Sci Rep"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/35078107"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi S.S.","year":"2023","unstructured":"Ali Zaidi S.S. et al: Engineering siRNA therapeutics: challenges and strategies. J Nanobiotechnology 2023; 21: 381.","journal-title":"J Nanobiotechnology"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.06.010"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2012.02.005"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/nar\/gkh247","article-title":"Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference","volume":"32","author":"Ui-Tei K.","year":"2004","unstructured":"Ui-Tei K. et al: Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 2004; 32: 936.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.02.157"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt936"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","DOI":"10.1002\/acg2.107","article-title":"An in silico analysis of effective siRNAs against COVID-19 by targeting the leader sequence of SARS-CoV-2","volume":"4","author":"Pandey A.K.","year":"2021","unstructured":"Pandey A.K. and Verma S.: An in silico analysis of effective siRNAs against COVID-19 by targeting the leader sequence of SARS-CoV-2. Adv CELL GENE Ther 2021; 4. p. e107.","journal-title":"Adv CELL GENE Ther"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104951"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2020.12.021"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.278"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025642","article-title":"MysiRNA-designer: a workflow for efficient siRNA design","volume":"6","author":"Mysara M.","year":"2011","unstructured":"Mysara M., Garibaldi J.M. and Elhefnawi M.: MysiRNA-designer: a workflow for efficient siRNA design. PLoS One 2011; 6: e25642.","journal-title":"PLoS One"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/mst010"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp033"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm699"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn250"},{"key":"e_1_3_5_29_2","doi-asserted-by":"crossref","first-page":"W448","DOI":"10.1093\/nar\/gkl214","article-title":"siVirus: web-based antiviral siRNA design software for highly divergent viral sequences","volume":"34","author":"Naito Y.","year":"2006","unstructured":"Naito Y. et al: siVirus: web-based antiviral siRNA design software for highly divergent viral sequences. Nucleic Acids Res 2006; 34: W448. (Web Server issue).","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"W135","DOI":"10.1093\/nar\/gkh449","article-title":"Sfold web server for statistical folding and rational design of nucleic acids","volume":"32","author":"Ding Y.","year":"2004","unstructured":"Ding Y., Chan C.Y. and Lawrence C.E.: Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res 2004; 32: W135. (Web Server issue).","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm088","article-title":"Comparison of approaches for rational siRNA design leading to a new efficient and transparent method","volume":"35","author":"Matveeva O.","year":"2007","unstructured":"Matveeva O. et al: Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res 2007; 35: e63.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027602","article-title":"siPRED: predicting siRNA efficacy using various characteristic methods","volume":"6","author":"Pan W.J.","year":"2011","unstructured":"Pan W.J., Chen C.W. and Chu Y.W.: siPRED: predicting siRNA efficacy using various characteristic methods. PLoS One 2011; 6: e27602.","journal-title":"PLoS One"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1118"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn188"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010180","article-title":"Optimization of duplex stability and terminal asymmetry for shRNA design","volume":"5","author":"Matveeva O.V.","year":"2010","unstructured":"Matveeva O.V. et al: Optimization of duplex stability and terminal asymmetry for shRNA design. PLoS One 2010; 5: e10180.","journal-title":"PLoS One"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx279"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl842"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"42211","DOI":"10.1074\/jbc.M111.296905","article-title":"Akt2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation","volume":"286","author":"Huang Q.","year":"2011","unstructured":"Huang Q. et al: Akt2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation. J Biol Chem 2011; 286: 42211.","journal-title":"J Biol Chem"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087379","article-title":"Crystal Violet Assay for Determining Viability of Cultured Cells","volume":"2016","author":"Feoktistova M.","year":"2016","unstructured":"Feoktistova M., Geserick P. and Leverkus M.: Crystal Violet Assay for Determining Viability of Cultured Cells. Cold Spring Harb Protoc 2016; 2016. p. pdb prot087379.","journal-title":"Cold Spring Harb Protoc"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(83)90303-4"},{"key":"e_1_3_5_41_2","unstructured":"Demonstration of a \u0394\u0394Cq Calculation Method to Compute Relative Gene Expression from qPCR Data Josh Haimes Melissa Kelley Dharmacon A Horizon Discovery Group Company Lafayette CO USA."},{"key":"e_1_3_5_42_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12985-020-01436-5","article-title":"Multiple gene targeting siRNAs for down regulation of Immediate Early-2 (Ie2) and DNA polymerase genes mediated inhibition of novel rat Cytomegalovirus (strain All-03)","volume":"17","author":"Balakrishnan K.N.","year":"2020","unstructured":"Balakrishnan K.N. et al: Multiple gene targeting siRNAs for down regulation of Immediate Early-2 (Ie2) and DNA polymerase genes mediated inhibition of novel rat Cytomegalovirus (strain All-03). Virol J 2020; 17: 164.","journal-title":"Virol J"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.12.014"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.03.007"},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01800","article-title":"Geographic and Genomic Distribution of SARS-CoV-2 Mutations","volume":"11","author":"Mercatelli D.","year":"2020","unstructured":"Mercatelli D. and Giorgi F.M.: Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front Microbiol 2020; 11.","journal-title":"Front Microbiol"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12020244"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109877","article-title":"Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19","volume":"143","author":"Biswas S.K.","year":"2020","unstructured":"Biswas S.K. and Mudi S.R.: Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19. Med Hypotheses 2020; 143: 109877.","journal-title":"Med Hypotheses"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-020-0808-9"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165878"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5357\/koubyou.80.1_15","article-title":"Role of ARID3A in E2F target gene expression and cell growth","volume":"80","author":"Saadat K.A.","year":"2013","unstructured":"Saadat K.A.: Role of ARID3A in E2F target gene expression and cell growth. Kokubyo Gakkai Zasshi 2013; 80: 15.","journal-title":"Kokubyo Gakkai Zasshi"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1073\/pnas.0437841100","article-title":"RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription","volume":"100","author":"Ge Q.","year":"2003","unstructured":"Ge Q. et al: RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci 2003; 100: 2718.","journal-title":"Proc Natl Acad Sci"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159211"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1093\/bioinformatics\/btr555","article-title":"The design of optimal therapeutic small interfering RNA molecules targeting diverse strains of influenza A virus","volume":"27","author":"ElHefnawi M.","year":"2011","unstructured":"ElHefnawi M. et al: The design of optimal therapeutic small interfering RNA molecules targeting diverse strains of influenza A virus. Bioinformatics 2011; 27: 3364.","journal-title":"Bioinformatics"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252758799"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302479"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.02.001"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290286"},{"key":"e_1_3_5_58_2","article-title":"Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract","volume":"23","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y. et al: Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. Int J Mol Sci 2022; 23.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_59_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.898192","article-title":"Role of COVID-19 Vaccines in SARS-CoV-2 Variants","volume":"13","author":"Zhou Z.","year":"2022","unstructured":"Zhou Z., Zhu Y. and Chu M.: Role of COVID-19 Vaccines in SARS-CoV-2 Variants. Front Immunol 2022; 13: 898192.","journal-title":"Front Immunol"},{"key":"e_1_3_5_60_2","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1283328","article-title":"Development of primer-probe sets to rapidly distinguish single nucleotide polymorphisms in SARS-CoV-2 lineages","volume":"13","author":"Ealand C.S.","year":"2023","unstructured":"Ealand C.S. et al: Development of primer-probe sets to rapidly distinguish single nucleotide polymorphisms in SARS-CoV-2 lineages. Front Cell Infect Microbiol 2023; 13.","journal-title":"Front Cell Infect Microbiol"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c01239"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"e_1_3_5_63_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105677","article-title":"Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2","volume":"217","author":"Bowden-Reid E.","year":"2023","unstructured":"Bowden-Reid E. et al: Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2. Antivir Res 2023; 217: 105677.","journal-title":"Antivir Res"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2023.2217400"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1280"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10280-3"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV120.013930"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17495-9"},{"key":"e_1_3_5_69_2","doi-asserted-by":"crossref","DOI":"10.1177\/11779322211025876","article-title":"Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins","volume":"15","author":"Gorkhali R.","year":"2021","unstructured":"Gorkhali R. et al: Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins. Bioinforma Biol Insights 2021; 15. 11779322211025876.","journal-title":"Bioinforma Biol Insights"},{"key":"e_1_3_5_70_2","article-title":"One Year of SARS-CoV-2: How Much Has the Virus Changed?","volume":"10","author":"Vilar S.","year":"2021","unstructured":"Vilar S. and Isom D.G.: One Year of SARS-CoV-2: How Much Has the Virus Changed?. Biol (Basel) 2021; 10.","journal-title":"Biol (Basel)"},{"key":"e_1_3_5_71_2","article-title":"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp\/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens","volume":"58","author":"Chan J.F.","year":"2020","unstructured":"Chan J.F. et al: Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp\/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens. J Clin Microbiol 2020; 58.","journal-title":"J Clin Microbiol"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa029"},{"key":"e_1_3_5_73_2","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman V.M.","year":"2020","unstructured":"Corman V.M. et al: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eur Surveill 2020; 25.","journal-title":"Eur Surveill"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00468-6"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15815"},{"key":"e_1_3_5_76_2","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219523120","article-title":"Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection","volume":"120","author":"Hariharan V.N.","year":"2023","unstructured":"Hariharan V.N. et al: Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection. Proc Natl Acad Sci 2023; 120: e2219523120.","journal-title":"Proc Natl Acad Sci"},{"key":"e_1_3_5_77_2","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115298","article-title":"A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant","volume":"14","author":"Chang Y.C.","year":"2022","unstructured":"Chang Y.C. et al: A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant. EMBO Mol Med 2022; 14: e15298.","journal-title":"EMBO Mol Med"},{"key":"e_1_3_5_78_2","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2020.526455","article-title":"siRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects","volume":"11","author":"Neumeier J.","year":"2020","unstructured":"Neumeier J. and Meister G.: siRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects. Front Plant Sci 2020; 11: 526455.","journal-title":"Front Plant Sci"},{"key":"e_1_3_5_79_2","unstructured":"Reports-of-suspected-adverse-reaction-to-COVID-19-vaccines-as-of-31-May-2023.pdf>\u2009."},{"key":"e_1_3_5_80_2","doi-asserted-by":"crossref","unstructured":"Reed L.J. and H. Muench A simple method of estimating fifty per cent endpoints. 1938.","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2021.100569"},{"key":"e_1_3_5_82_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2021.100910","article-title":"Design of advanced siRNA therapeutics for the treatment of COVID-19","volume":"29","author":"Niktab I.","year":"2021","unstructured":"Niktab I. et al: Design of advanced siRNA therapeutics for the treatment of COVID-19. Meta Gene 2021; 29: 100910.","journal-title":"Meta Gene"},{"key":"e_1_3_5_83_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/ijmr.IJMR_2855_20","article-title":"Prediction of potential small interfering RNA molecules for silencing of the spike gene of SARS-CoV-2","volume":"153","author":"Panda K.","year":"2021","unstructured":"Panda K. et al: Prediction of potential small interfering RNA molecules for silencing of the spike gene of SARS-CoV-2. Indian J. Med. Res. 2021; 153: 182.","journal-title":"Indian J. Med. Res."},{"key":"e_1_3_5_84_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s43141-022-00346-z","article-title":"Design of siRNA molecules for silencing of membrane glycoprotein, nucleocapsid phosphoprotein, and surface glycoprotein genes of SARS-CoV2","volume":"20","author":"Ayyagari V.S.","year":"2022","unstructured":"Ayyagari V.S.: Design of siRNA molecules for silencing of membrane glycoprotein, nucleocapsid phosphoprotein, and surface glycoprotein genes of SARS-CoV2. J. Genet. Eng. Biotechnol. 2022; 20: 65.","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"e_1_3_5_85_2","doi-asserted-by":"crossref","first-page":"801870","DOI":"10.3389\/fbioe.2022.801870","article-title":"Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2","volume":"10","author":"Friedrich M.","year":"2022","unstructured":"Friedrich M. et al: Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2. Front Bioeng Biotechnol 2022; 10: 801870.","journal-title":"Front Bioeng Biotechnol"},{"key":"e_1_3_5_86_2","doi-asserted-by":"crossref","unstructured":"Sartaj Sohrab S. Aly El-Kafrawy S. and Ibraheem Azhar E.: : J King Saud Univ Sci 2022: 102049.","DOI":"10.1016\/j.jksus.2022.102049"},{"key":"e_1_3_5_87_2","doi-asserted-by":"crossref","first-page":"e15298","DOI":"10.15252\/emmm.202115298","article-title":"A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant","volume":"14","author":"Chang Y.C.","year":"2022","unstructured":"Chang Y.C. et al: A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant. EMBO Mol Med 2022; 14: e15298.","journal-title":"EMBO Mol Med"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037025001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2025.03.034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:32:17Z","timestamp":1775219537000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2025.03.034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":86,"alternative-id":["10.1016\/j.csbj.2025.03.034"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2025.03.034","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2025.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}